Flow cytometric analysis of Human CD155/PVR expression on human PBMC (human peripheral blood mononuclear cell). Human PBMC were stained with either FITC Mouse IgG1, κ Isotype Control (Left panel) or FITC Mouse Anti-Human CD57 Antibody (Right panel) at 5 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD57 |
Synonyms | HNK-1; Leu-7 |
Location | Cell membrane |
Clone Number | S-3011 |
Antibody Type | Mouse mAb |
Isotype | IgG2a,k |
Application | FCM |
Reactivity | Hu |
Positive Sample | human PBMC |
Purification | Protein A |
Concentration | 0.2 mg/ml |
Conjugation | FITC |
Physical Appearance | Liquid |
Storage Buffer | PBS, 1% BSA, 0.3% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
FCM | 5μl per million cells in 100μl volume | Hu |
Background
CD57 (also designated HNK-1 or Leu-7) is not a protein per se, but a carbohydrate epitope synthesized by the enzymatic action of beta-1,3-glucuronyltransferase 1 (B3GAT1), a type-II membrane protein encoded by the B3GAT1 gene on chromosome 11q25; this enzyme transfers glucuronic acid to terminal N-acetyllactosamine to form the sulfated CD57 determinant on a variety of cell-surface proteins, lipids and chondroitin sulfate proteoglycans, conferring the antigen that marks subsets of terminally differentiated natural killer and CD8+ cytotoxic T lymphocytes, as well as certain neural and muscle cells, and is implicated in neural cell adhesion and the delineation of late-stage lymphocyte maturation.
Picture
Picture
FC
